The diagnosis of interstitial lung disease (ILD) can be difficult, especially in the early stages when pulmonary function tests (PFTs) show only minor changes. To improve the effectiveness of early diagnosis, researchers wanted to evaluate the potential of artificial intelligence (AI)-based software to support pulmonary specialists in analyzing PFT results.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Irritable Bowel Syndrome
“Best practice” recommendations for step-by-step clarification and stage-adapted therapy
- Nutritional supplements and cognition
5-HTP: The serotonin booster for cognition in old age
- Pulmonary hypertension
PH and lung diseases
- CRC, AML and melanoma in focus
Molecular mechanisms of tumor plasticity
- Friedreich's ataxia
Interim analyses of the PROFA study show “Unmet needs”
- Polypharmacy: use of eHealth tools in Switzerland
Survey study in primary care
- Treatment of type 2 diabetes: paradigm shift continues
Cardiorenal organ protection is increasingly coming to the fore
- Study report